US STOCKS-Wall St mixed as doubts about earnings offset biotech M&A bid

martes 21 de abril de 2015 15:16 GYT

* Yahoo, Chipotle, Yum to report after the close

* Mylan shares up almost 10 pct after Teva bid

* Dow off 0.45 pct, S&P down 0.1 pct, Nasdaq up 0.48 pct (Updates to afternoon)

By Noel Randewich

April 21 (Reuters) - U.S. stocks were mixed on Tuesday, with the Dow industrials pulled down by a handful of uninspiring earnings reports, while the Nasdaq was pushed higher by a proposed biotech merger.

Travelers, DuPont and IBM shares weighed on the Dow. DuPont reported lower sales in all of its businesses and said a strong dollar would take a toll on its full-year earnings. IBM also mentioned currency effects when it reported a fall in revenue late on Monday.

DuPont was down 2.73 percent at $70.84 and IBM fell 1.14 percent.

March-quarter earnings season is in full swing, with almost 73 percent of the S&P 500 components that have reported so far beating bottom-line expectations, but just 42.2 percent beating expectations for revenue.

Investors are gauging how much a strong dollar has hurt U.S. multinationals, including technology companies like Facebook , Google, Qualcomm, Microsoft that sell many of their products and services overseas and are expected to report their earnings this week.   Continuación...